Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: Transactivation by ATF1

Virology

Volumn 227, Issue 2, 1997, Pages 323-330

  Wang, Yi Chun James ^a   Huang, Jung Ming ^a   Montalvo, Eduardo A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; TRANSCRIPTION REGULATION; VIRUS REACTIVATION;

ANIMALIA; HUMAN HERPESVIRUS 4;

EID: 0031579240     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8326     Document Type: Article

References (38)

1. Angel, P., Hattori, K., Smeal, T., and Karin, M. (1988). The jun protooncogene is positively autoregulated by its product, Jun/AP1. Cell 55, 875-885.
2. Bauer, G., Hofler, P., and zur Hausen, H. (1982). Epstein-Barr virus induction by a serum factor. Virology 121, 184-194.
3. Biggin, M., Bodescot, M., Perricaudet, M., and Farrell, P. (1987). Epstein-Barr virus gene expression in P3HR-1 superinfected Raji cells. J. Virol. 61, 3120-3132.
4. Brown, T. (1993). Analysis of RNA by Northern and slot blot hybridization. In Current Protocols in Molecular Biology (F. M. Ausubel, R. Brent, R. E. Kingston, et al., Eds), pp. 9.2.1-9.2.6, Green and Wiley-Interscience, New York.
5. Chevallier, G. A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J., and Sergeant, A. (1986). Both Epstein-Barr virus (EBV)-encoded transacting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 5, 3243-3249.
6. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
7. Chow, V. T. (1993). Cancer and viruses. Ann. Acad. Med. Singapore 22, 163-169.
8. Countryman, J., and Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA 82, 4085-4089.
9. Daibata, M., Speck, S. H., Mulder, C., and Sairenji, T. (1994). Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells. Virology 198, 446-454.
10. Dignam, J. D., Lebovitz, M., and Roeder, R. G. (1983). Accurate transcription by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
11. Faggioni, A., Zompetta, C., Grimaldi, S., Barile, G., Frati, L., and Lazdins, J. (1986). Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science 232, 1554-1556.
12. Flamand, L., and Menezes, J. (1996). Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J. Virol. 70, 1784-1791.
13. Flemington, E., and Speck, S. H. (1990a). Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64, 1217-1226.
14. Remington, E., and Speck, S. H. (1990b). Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64, 1227-123
15. Garcia-Blanco, M. A., and Cullen, B. R. (1991). Molecular basis of latency in pathogenic human viruses. Science 254, 815-820.
16. Georgopoulos, K., Morgan, B. A., and Moore, D. D. (1992). Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer. Mol. Cell. Biol. 12, 747-757.
17. Hsueh, Y. P., and Lai, M. Z. (1995). Overexpression of activation transcription factor 1 in lymphomas and in activated lymphocytes. J. Immunol. 154, 5675-5683.
18. Kaszubska, W., van, H. R., Ghersa, P., DeRaemy, S. A., Chen, B. P., Hai, T., DeLamarter, J. F., and Whelan, J. (1993). Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol. Cell. Biol. 13, 7180-7190.
19. Laux, G., Freese, U. K., Fischer, R., Polack, A., Kofler, E., and Bornkamm, G. W. (1988). TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology 162, 503-507.
20. Leiden, J. M. (1993). Transcriptional regulation of T cell receptor genes. Annu. Rev. Immunol. 11, 539-570.
21. Liebowitz, D. (1994). Nasopharyngeal carcinoma: The Epstein-Barr virus association. Semin. Oncol. 21, 376-381.
22. Luka, J., Kallin, B., and Klein, G. (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94, 228-231.
23. Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., and Thorley-Lawson, D. A. (1995). A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80, 593-601.
24. Montalvo, E. A., Cottam, M., Hill, S., and Wang, Y.-C. J. (1995). YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J. Virol. 69, 4158-4165.
25. Montalvo, E. A., Shi, Y., Shenk, T. E., and Levine, A. J. (1991). Negative regulation of the BZLF1 promoter of Epstein-Barr virus. J. Virol. 65, 3647-3655.
26. Niedobitek, G., Herbst, H., Young, L. S., Rowe, M., Dienemann, D., Germer, C., and Stein, H. (1992). Epstein-Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma. Diagn. Mol. Pathol. 1, 103-108.
27. Raab-Traub, N. (1992). Epstein-Barr virus and nasopharyngeal carcinoma Semin. Cancer Biol. 3, 297-307.
28. Roesler, W. J., Vandenbark, G. R., and Hanson, R. W. (1988). Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263, 9063-9066.
29. Ruf, I. K., and Rawlins, D. R. (1995). Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter. J. Virol. 69, 7648-7657.
30. Schwarzmann, F., Prang, N., Reichelt, B., Rinkes, B., Haist, S., Marschall, M., and Wolf, H. (1994). Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J. Gen. Virol. 75, 1999-2006.
31. Selden, R. F. (1993). Transfection using DEAE-dextran. In Current Protocols in Molecular Biology (F. M. Ausubel, R. Brent, R. E. Kingston, et al., Eds.), pp. 9.2.1-9.2.6, Green and Wiley-Interscience, New York.
32. Shimizu, N., and Takada, K. (1993). Analysis of the BZLF1 promoter of Epstein-Barr virus: Identification of an anti-immunoglobulin response sequence. J. Virol. 67, 3240-3245.
33. Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., and Pagano, J. S. (1984). Epstein-Barr virus replication in oropharyngeal cells. Mol. Cell. Biol. 310, 1225-1230.
34. Takada, K. (1984). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33, 27-32.
35. Takada, K., and Ono, Y. (1989). Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63, 445-449.
36. Takada, K., Shimizu, N., Sakuma, S., and Ono, Y. (1986). trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J. Virol. 57, 1016-1022.
37. Tovey, M. G., Lenoir, G., and Begon-Lours, J. (1978). Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276, 270-272.
38. zur Hansen, H., O'Neill, F. J., Freese, U. K., and Hecker, E. (1978). Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272, 373-375.